Literature DB >> 11191365

Susceptibility to ischemia-induced arrhythmias and the effect of preconditioning in the diabetic rat heart.

T Ravingerová1, R Stetka, D Pancza, O Ulicná, A Ziegelhöffer, J Styk.   

Abstract

Diabetic heart is suggested to exhibit either increased or decreased resistance to ischemic injury. Ischemic preconditioning suppresses arrhythmias in the normal heart, whereas relatively little is known about its effects in the diseased myocardium. Our objective was to investigate whether development of diabetes mellitus modifies the susceptibility to ischemia-induced arrhythmias and affects preconditioning in the rat heart. Following 1 and 9 weeks of streptozotocin-induced (45 mg/kg, i.v.) diabetes, the hearts were Langendorff-perfused at constant pressure of 70 mm Hg and subjected to test ischemia induced by 30 min occlusion of the left anterior descending (LAD) coronary artery. Preconditioning consisted of one cycle of 5 min ischemia and 10 min reperfusion, prior to test ischemia. Susceptibility to ischemia-induced arrhythmias was lower in 1-week diabetics: only 42 % of diabetic hearts exhibited ventricular tachycardia (VT) and 16 % had short episodes of ventricular fibrillation (VF) as compared to VT 100 % and VF 70 % (including sustained VF 36 %) in the non-diabetics (P<0.05). Development of the disease was associated with an increased incidence of VT (VT 92 %, not significantly different from non-diabetics) and longer total duration of VT and VF at 9-weeks, as compared to 1-week diabetics. Preconditioning effectively suppressed arrhythmias in the normal hearts (VT 33 %, VF 0 %). However, it did not provide any additional antiarrhythmic protection in the acute diabetes. On the other hand, in the preconditioned 9-weeks diabetic hearts, the incidence of arrhythmias tended to decrease (VT 50 %, transient VF 10 %) and their severity was reduced. Diabetic rat hearts are thus less susceptible to ischemia-induced arrhythmias in the acute phase of the disease. Development of diabetes attenuates increased ischemic tolerance, however, diabetic hearts in the chronic phase can benefit more from ischemic preconditioning, due to its persisting influence.

Entities:  

Mesh:

Year:  2000        PMID: 11191365

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  13 in total

1.  Insulin suppresses ischemic preconditioning-mediated cardioprotection through Akt-dependent mechanisms.

Authors:  Tanner M Fullmer; Shaobo Pei; Yi Zhu; Crystal Sloan; Robert Manzanares; Brandon Henrie; Karla M Pires; James E Cox; E Dale Abel; Sihem Boudina
Journal:  J Mol Cell Cardiol       Date:  2013-08-30       Impact factor: 5.000

Review 2.  Autophagy, myocardial protection, and the metabolic syndrome.

Authors:  Zoltan Giricz; Robert M Mentzer; Roberta A Gottlieb
Journal:  J Cardiovasc Pharmacol       Date:  2012-08       Impact factor: 3.105

3.  Pacing postconditioning: impact of pacing algorithm, gender, and diabetes on its myocardial protective effects.

Authors:  Fawzi A Babiker; Jolanda van Golde; Ward Y Vanagt; Frits W Prinzen
Journal:  J Cardiovasc Transl Res       Date:  2012-07-24       Impact factor: 4.132

Review 4.  Protection of the abnormal heart.

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

5.  Absence of ischemic preconditioning protection in diabetic sheep hearts: role of sarcolemmal KATP channel dysfunction.

Authors:  Héctor F del Valle; Elena C Lascano; Jorge A Negroni; Alberto J Crottogini
Journal:  Mol Cell Biochem       Date:  2003-07       Impact factor: 3.396

6.  Metallothionein as an adaptive protein prevents diabetes and its toxicity.

Authors:  Lu Cai
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-04

7.  Resistance of the myocardium to ischemia and the efficacy of ischemic preconditioning in experimental diabetes mellitus.

Authors:  M M Galagudza; M K Nekrasova; A V Syrenskii; E M Nifontov
Journal:  Neurosci Behav Physiol       Date:  2007-06

8.  Metabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF rats.

Authors:  Márta Sárközy; Agnes Zvara; Nóra Gyémánt; Veronika Fekete; Gabriella F Kocsis; Judit Pipis; Gergő Szűcs; Csaba Csonka; László G Puskás; Péter Ferdinandy; Tamás Csont
Journal:  Cardiovasc Diabetol       Date:  2013-01-15       Impact factor: 9.951

Review 9.  The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities.

Authors:  Kieran McCafferty; Suzanne Forbes; Christoph Thiemermann; Muhammad M Yaqoob
Journal:  Dis Model Mech       Date:  2014-12       Impact factor: 5.758

10.  High carbohydrate and high fat diets protect the heart against ischaemia/reperfusion injury.

Authors:  Ruduwaan Salie; Barbara Huisamen; Amanda Lochner
Journal:  Cardiovasc Diabetol       Date:  2014-07-18       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.